HHS Will Begin Distributing Regeneron’s Monoclonal Antibodies Tuesday

By Kelly Lienhard / November 23, 2020 at 8:03 PM

On Tuesday (Nov. 24), HHS will begin allocating the first 30,000 doses of Regeneron’s investigational monoclonal antibodies, casirivimab and imdevimab, which over the weekend received emergency use authorization from FDA for use in non-hospitalized patients with mild to moderate COVID-19.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.